High Prevalence of Chronic Diseases and Emergence of Covid-19 to Augment Growth of Patient Engagement Solution Market

 


High prevalence of chronic diseases is expected to propel growth of the global patient engagement solution market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050.        

Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global patient engagement solution market. For instance, globally, as of 5:15pm CET, 14 February 2021, there have been 108,153,741 confirmed cases of COVID-19, including 2,381,295 deaths, as reported to the World Health Organization. Moreover, increasing adoption of cloud communications solutions is also expected to aid in growth of the market. For instance, in September 2020, ENT and Allergy Associates, LLP, a healthcare facility that provides adult and pediatric ENT services, partnered with RingCentral to utilize its cloud communications solution.

However, risk regarding data security and lack of IT expertise, especially in emerging economies, is o expected to hinder growth of the global patient engagement solutions market.

Among regions, North America is expected to witness significant growth in the patient engagement solution market, owing to increasing adoption of patient engagement solutions in the region. For instance, in August 2020, Continuing Care Center of Ojai Valley Community Hospital, U.S. implemented eVideon’s patient experience platform and digital signage solutions.

Competitive Analysis

Major players operating in the global patient engagement solution market include, Medecision, Inc., Cerner Corporation, Phytel, Inc., iMD Health Global Corp., Axial Exchange, Orion Health, Emmi Solutions LLC, Athenahealth, Inc., RingCentral, InteliChart, Radix Health, GetWellNetwork, Inc., Pomelo Health, eVideon, Caravan Health, and SeamlessMD.

Major players operating in the global patient engagement solution market are focused on launching new products to expand their product portfolio. For instance, in April 2020, Caravan Health launched a COVID-19 patient engagement application in the U.S.

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more